| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.55B | 47.48B | 55.05B | 31.03B | 25.51B | 17.91B |
| Gross Profit | -8.67B | 3.15B | 18.25B | 22.40B | 1.48B | 962.00M |
| EBITDA | 4.79B | 4.53B | 3.62B | 2.74B | 2.35B | 1.28B |
| Net Income | 2.04B | 1.93B | 1.84B | 1.31B | 1.11B | 357.00M |
Balance Sheet | ||||||
| Total Assets | 29.77B | 26.70B | 24.35B | 21.48B | 18.75B | 14.87B |
| Cash, Cash Equivalents and Short-Term Investments | 523.00M | 574.69M | 623.00M | 1.03B | 1.99B | 1.84B |
| Total Debt | 9.13B | 6.99B | 5.91B | 5.27B | 5.04B | 4.48B |
| Total Liabilities | 21.70B | 18.94B | 17.44B | 15.18B | 12.84B | 9.95B |
| Stockholders Equity | 7.95B | 7.65B | 6.83B | 6.26B | 5.87B | 4.89B |
Cash Flow | ||||||
| Free Cash Flow | 3.01B | 2.99B | 2.23B | 1.83B | 1.31B | 943.00M |
| Operating Cash Flow | 3.64B | 3.55B | 3.13B | 2.54B | 1.60B | 1.17B |
| Investing Cash Flow | -3.23B | -2.58B | -1.26B | -1.23B | -874.00M | -769.45M |
| Financing Cash Flow | -561.27M | -1.07B | -1.53B | -2.58B | -693.00M | -153.89M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £339.86M | 17.12 | 4.99% | 2.81% | 6.94% | 9.13% | |
75 Outperform | $55.79B | 27.37 | 26.24% | 2.34% | 10.63% | 37.99% | |
66 Neutral | £290.17M | 3.89 | 9.30% | ― | -0.52% | 68.53% | |
65 Neutral | £1.40B | 7.66 | 6.41% | ― | 2.96% | 9.30% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | £623.53M | 11.83 | 15.81% | 1.50% | 5.39% | -3.64% | |
50 Neutral | £1.29B | -45.56 | -65.76% | 2.50% | 4.58% | -24.15% |